Mangalam Drugs and Organics Limited has submitted a compliance certificate for the quarter ended December 31, 2025, as required under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

The certificate was received from MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent. It confirms that securities received for dematerialization during the quarter were processed and confirmed with the depositories. The registrar also verified that the security certificates were mutilated and cancelled, with the depositories' names substituted in the register of members within the prescribed timelines.

The company has requested that the stock exchanges take this certificate on record.